Citations

Citations to this article as recorded by  

• Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study
  Jebyung Park, Sung Noh Hong, Hong Sub Lee, Jongbeom Shin, Eun Hye Oh, Kwangwoo Nam, Gyeol Seong, Hyun Gun Kim, Jin-Oh Kim, Seong Ran Jeon
  The Korean Journal of Internal Medicine.2024; 39(5): 783.     CrossRef

Citations

Citations to this article as recorded by  

• Ipilimumab, -omics, and head and neck cancers—update in 2025
  Robert Kucharski, Adam Kosiński, Leszek Kalinowski, Karolina Kaźmierczak-Siedlecka
  Frontiers in Immunology.2026;[Epub]     CrossRef
• Immune-Mediated Colitis Induced by Immune Checkpoint Inhibitors: Pathophysiology, Clinical Management, and the Emerging Role of Fecal Microbiota Transplantation
  Zeljka Belosic Halle, Vedran Tomasic, Alen Biscanin, Petra Cacic, Ivona Saric, Sanda Mustapic, Josip Stojic, Kresimir Luetic, Dinko Bekic, Matej Paic, Domagoj Micetic, Irena Krznaric Zrnic, Ivna Olic, Melanija Razov Radas, Iva Skocilic, Marin Golčic, Laur
  Biomedicines.2026; 14(3): 683.     CrossRef
• What should intensivists know about immune checkpoint inhibitors and their side effects?
  Viktor Yordanov Zlatkov Aleksandrov, Fernando Martínez Sagasti, Juncal Pérez-Somarriba Moreno, Helena Huertas Mondéjar
  Medicina Intensiva (English Edition).2025; 49(7): 502135.     CrossRef
• The association between metformin use, immune mediated colitis and overall survival in patients treated with checkpoint inhibitor
  Malek Shatila, Carolina Colli Cruz, Linfeng Lu, Kian Abdul-baki, Elliot Baerman, Kei Takigawa, Andres Urias Rivera, Irene Jeong-Ah Lee, Sean Ngo, Gabriel Sperling, Abdullah Sagar Aleem, Raakhi Menon, Andrew Sullivan, Varun Vemulapalli, Cristina Natha, Tan
  European Journal of Cancer.2025; 221: 115405.     CrossRef
• What should intensivists know about immune checkpoint inhibitors and their side effects?
  Viktor Yordanov Zlatkov Aleksandrov, Fernando Martínez Sagasti, Juncal Pérez-Somarriba Moreno, Helena Huertas Mondéjar
  Medicina Intensiva.2025; 49(7): 502135.     CrossRef
• Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review
  Mehran Mahooti, Fatemeh Safaei, Faezeh Firuzpour, Elahe Abdolalipour, Davood Zare, Samira Sanami, Maliheh Safavi, Saeed Mirdamadi
  Inflammopharmacology.2025; 33(7): 3823.     CrossRef
• Refractory Immune Checkpoint Inhibitor Colitis Treated With Biologics, Janus Kinase Inhibition, Plasma Exchange, and Fecal Microbiota Transplantation
  Jason Hearn, Getanshu Malik, Igor Stukalin, Remo Panaccione, Richard J.M. Ingram, Christopher Ma
  ACG Case Reports Journal.2025;[Epub]     CrossRef
• Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
  Despoina Chrysostomou, Lauren A. Roberts, Julian R. Marchesi, James M. Kinross
  Gastroenterology.2023; 164(2): 198.     CrossRef
• Compositional changes in fecal microbiota associated with clinical phenotypes and prognosis in Korean patients with inflammatory bowel disease
  Seung Yong Shin, Young Kim, Won-Seok Kim, Jung Min Moon, Kang-Moon Lee, Sung-Ae Jung, Hyesook Park, Eun Young Huh, Byung Chang Kim, Soo Chan Lee, Chang Hwan Choi
  Intestinal Research.2023; 21(1): 148.     CrossRef
• Obesity Measured via Body Mass Index May Be Associated with Increased Incidence but Not Worse Outcomes of Immune-Mediated Diarrhea and Colitis
  Miho Kono, Malek Shatila, Guofan Xu, Yang Lu, Antony Mathew, Wasay Mohajir, Krishnavathana Varatharajalu, Wei Qiao, Anusha S. Thomas, Yinghong Wang
  Cancers.2023; 15(8): 2329.     CrossRef
• Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy
  Ankita Singh, Sharon Grace Alexander, Sunil Martin
  Frontiers in Immunology.2023;[Epub]     CrossRef
• Gut Microbiome and Colorectal Cancer
  Tae-Geun Gweon
  The Korean Journal of Gastroenterology.2023; 82(2): 56.     CrossRef
• Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors
  Patrick T Magahis, Steven B Maron, Darren Cowzer, Stephanie King, Mark Schattner, Yelena Janjigian, David Faleck, Monika Laszkowska
  Journal for ImmunoTherapy of Cancer.2023; 11(10): e007699.     CrossRef
• Comments on Efficacy of a Synbiotic Containing Lactobacillus paracasei DKGF1 and Opuntia humifusa in Elderly Patients with Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
  Kwang Woo Kim
  Gut and Liver.2023; 17(6): 954.     CrossRef
• MTA1 aggravates experimental colitis in mice by promoting transcription factor HIF1A and up-regulating AQP4 expression
  Ping Li, Dong-Ping Shi, Tao Jin, Dong Tang, Wei Wang, Liu-Hua Wang
  Cell Death Discovery.2022;[Epub]     CrossRef
• Crosstalk between mucosal microbiota, host gene expression, and sociomedical factors in the progression of colorectal cancer
  Namjoo Kim, Jeong-An Gim, Beom Jae Lee, Byung il Choi, Hee Sook Yoon, Seung Han Kim, Moon Kyung Joo, Jong-Jae Park, Chungyeul Kim
  Scientific Reports.2022;[Epub]     CrossRef
• Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea
  Gi-Ung Kang, Sowon Park, Yeongyun Jung, Jai J. Jee, Min-Sueng Kim, Seungjun Lee, Dong-Woo Lee, Jae-Ho Shin, Hong Koh
  Gut and Liver.2022; 16(5): 775.     CrossRef
• Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
  Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet, Victoire Cardot-Ruffino
  Cancers.2022; 14(21): 5402.     CrossRef
• Microbial Modulation in Inflammatory Bowel Diseases
  Jongwook Yu, Jae Hee Cheon
  Immune Network.2022;[Epub]     CrossRef
• Immune Checkpoint Inhibitor-Associated Colitis: From Mechanism to Management
  Liansha Tang, Jialing Wang, Nan Lin, Yuwen Zhou, Wenbo He, Jiyan Liu, Xuelei Ma
  Frontiers in Immunology.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients
  Asghar Ali, Khalid I. AlHussaini
  Frontiers in Microbiology.2026;[Epub]     CrossRef
• Baseline Gut Microbiome-Dependent Responses to Probiotic Treatments for IBD in Mice
  Zeng Zhang, Zhihan Yang, Shuaiming Jiang, Yukai Sun, Yuesong Jiang, Shi Huang, Jiachao Zhang
  Engineering.2026;[Epub]     CrossRef
• Clinical characteristics and risk factors analysis of Clostridioides difficile infection in ulcerative colitis patients during biologic therapy
  Tingting Xu, Ying Xie
  Frontiers in Cellular and Infection Microbiology.2026;[Epub]     CrossRef
• Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection
  Krista Vitikainen, Merit Kase, Leo Meriranta, Pauliina Molander, Clas-Göran af Björkesten, Veli-Jukka Anttila, Perttu Arkkila
  Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
• Discordance in Clinical Indicators With Sequential Fecal Microbiota Transplantation: A Case of Fulminant Clostridioides Difficile Infection
  Peter Bhandari, Reanay Berezovskiy, Salima Makhani, Valerie Gausman, Neelesh Rastogi, Sabina Braude
  ACG Case Reports Journal.2025; 12(6): e01731.     CrossRef
• Phage therapy modulates the gut microbiome and immune responses in non-typhoidal Salmonella-induced colitis
  Md. Sharifull Islam, Ping Wei, Kaimin Zhang, Ishatur Nime, Fan Pan
  Food Research International.2025; 219: 117003.     CrossRef
• Recurrent Clostridium difficile Infections in a Patient With Ulcerative Colitis: A Case Report
  Osama Nadeem, Muhammad Soban Imran, Nasir Siddique
  Cureus.2025;[Epub]     CrossRef
• Patient with Inflammatory Bowel Disease in a Dental Office—Which Antibiotic to Choose?—Narrative Review
  Stanisław Niemczyk, Wojciech Niemczyk, Katarzyna Bąk-Drabik, Katarzyna Latusek-Kotyczka, Anna Zawilska, Rafał Wiench, Jakub Hadzik, Marzena Dominiak
  Journal of Clinical Medicine.2025; 14(23): 8392.     CrossRef
• Enteric opportunistic infections in patients with inflammatory bowel disease receiving biologic therapies: a retrospective cohort study
  Ting-Chieh Huang, Tony Kou, Chia-Jung Kuo, Cheng-Hsun Chiu, Tai-Di Chen, Chien-Ming Chen, Jen-Wei Chou, Tien-Yu Huang, Chen-Wang Chang, Cheng-Tang Chiu, Ming-Yao Su, Yu-Bin Pan, Puo-Hsien Le
  Gut Pathogens.2025;[Epub]     CrossRef
• Special Issue “Bacterial Toxins and Cancer”
  Sara Travaglione, Francesca Carlini, Zaira Maroccia, Alessia Fabbri
  International Journal of Molecular Sciences.2024; 25(4): 2128.     CrossRef
• 19-Year-Old Man With Abdominal Pain, Vomiting, Bloody Diarrhea, and Rash
  David L. Farrier, David Chiang, Amindra S. Arora
  Mayo Clinic Proceedings.2024; 99(6): 980.     CrossRef
• Pharmacological effects of ginseng and ginsenosides on intestinal inflammation and the immune system
  Linxian Zhao, Tongbo Zhang, Kai Zhang
  Frontiers in Immunology.2024;[Epub]     CrossRef
• Clostridioides difficile infection in inflammatory bowel disease: a clinical review
  Mengjun Tang, Chunhua Wang, Ying Xia, Jian Tang, Jiao Wang, Liang Shen
  Expert Review of Anti-infective Therapy.2024; 22(5): 297.     CrossRef
• Management of Clostridioides difficile infection: an Italian Delphi consensus
  Matteo Bassetti, Antonio Cascio, Francesco Giuseppe De Rosa, Marianna Meschiari, Roberto Parrella, Nicola Petrosillo, Alessandro Armuzzi, Flavio Caprioli, Francesco Dentali, Marcello Pani, Alberto Pilotto, Umberto Restelli, Maurizio Sanguinetti
  Journal of Antimicrobial Chemotherapy.2024; 79(9): 2103.     CrossRef
• Treatment outcomes of mild to moderate Clostridioides difficile infection in inflammatory bowel disease: an Australian experience
  Rachael Jacob, Virginia Chu, Watson Ng, Astrid‐Jane Williams, Susan Connor
  Internal Medicine Journal.2024; 54(12): 2009.     CrossRef
• Clinical outcomes for Clostridioides difficile associated diarrhea in inflammatory bowel disease patients versus non-IBD population: A retrospective cohort study
  Genady Drozdinsky, Alaa Atamna, Hagar Banai, Haim Ben-Zvi, Jihad Bishara, Noa Eliakim-Raz
  Medicine.2023; 102(6): e32812.     CrossRef
• Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?
  Katia Fettucciari, Alessandro Fruganti, Fabrizio Stracci, Andrea Spaterna, Pierfrancesco Marconi, Gabrio Bassotti
  International Journal of Molecular Sciences.2023; 24(9): 8155.     CrossRef
• Low prevalence of Clostridioides difficile infection in acute severe ulcerative colitis: A retrospective cohort study from northern India
  Sandeep Mundhra, David Thomas, Saransh Jain, Pabitra Sahu, Sudheer Vuyyuru, Peeyush Kumar, Bhaskar Kante, Rajesh Panwar, Peush Sahni, Rama Chaudhry, Prasenjit Das, Govind Makharia, Saurabh Kedia, Vineet Ahuja
  Indian Journal of Gastroenterology.2023; 42(3): 411.     CrossRef
• Risk of all-cause and cause-specific mortality associated with immune-mediated inflammatory diseases in Korea
  Oh Chan Kwon, See Young Lee, Jaeyoung Chun, Kyungdo Han, Yuna Kim, Ryul Kim, Min-Chan Park, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park
  Frontiers in Medicine.2023;[Epub]     CrossRef
• Fidaxomicin treatment for Clostridioides difficile infection in patients with inflammatory bowel disease
  Andree H Koop, Paul M Travers, Sahil Khanna, Darrell S Pardi, Francis A Farraye, Jana G Hashash
  Journal of Gastroenterology and Hepatology.2023; 38(11): 1910.     CrossRef
• Clostridioides difficile Infection in Inflammatory Bowel Disease Patients: A Systematic Review of Risk Factors and Approach in Management
  Leslie Sangurima, Maujid Masood Malik, Nency Ganatra, Rosemary Siby, Sanjay Kumar, Sara Khan, Doju Cheriachan, Lubna Mohammed
  Cureus.2023;[Epub]     CrossRef
• Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Clostridioides difficile Toxin A and Toxin B
  Katia Fettucciari, Fabrizio Dini, Pierfrancesco Marconi, Gabrio Bassotti
  Biology.2023; 12(8): 1117.     CrossRef
• Gut Microbiota Associated with Clostridioides difficile Carriage in Three Clinical Groups (Inflammatory Bowel Disease, C. difficile Infection and Healthcare Workers) in Hospital Field
  Elisa Martinez, Sebastien Crevecoeur, Carine Thirion, Jessica Grandjean, Papa Abdoulaye Fall, Marie-Pierre Hayette, Moutschen Michel, Bernard Taminiau, Edouard Louis, Georges Daube
  Microorganisms.2023; 11(10): 2527.     CrossRef
• Prevalence of Clostridium Difficile Infection (CDI) among Inflammatory Bowel Disease (IBD) Patients in Comparison to Non-IBD Patients in King Abdulaziz Medical City in Jeddah
  Ghassan Abdulrahman Sukkar, Syed Sameer Aga, Abdulrahman Hamid Alsamadani, Faisal Ghazi Almalki, Ali Saleh Alsudais, Abdulrahman Sulaiman Alquzi, Mohamed Eldigire Ahmed, Mushtaq Ahmad Mir, Moudi M. Alasmari, Shivendra Singh
  Interdisciplinary Perspectives on Infectious Diseases.2023; 2023: 1.     CrossRef
• Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis
  Eun Soo Kim, Kyeong Ok Kim, Byung Ik Jang, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Joon Seop Lee, Sung Kook Kim, Yun Jin Jung, Sang-Bum Kang, Manasi Agrawal, Ryan Ungaro, Jean-Frederic Colombel
  Digestive Diseases and Sciences.2022; 67(7): 2866.     CrossRef
• Risk factors for Clostridioides difficile infection in children and adolescents with inflammatory bowel disease: a systematic review and meta-analysis
  Sheng-Bo Fang, Yan-Qing Song, Chun-Yan Zhang, Li-Bo Wang
  World Journal of Pediatrics.2022; 18(1): 27.     CrossRef
• Clostridium innocuum infection in hospitalised patients with inflammatory bowel disease
  Puo-Hsien Le, Cheng-Tang Chiu, Pai-Jui Yeh, Yu-Bin Pan, Cheng-Hsun Chiu
  Journal of Infection.2022; 84(3): 337.     CrossRef
• Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
  Quan Lu, Mei-feng Yang, Yu-jie Liang, Jing Xu, Hao-ming Xu, Yu-qiang Nie, Li-sheng Wang, Jun Yao, De-feng Li
  Journal of Inflammation Research.2022; Volume 15: 1825.     CrossRef
• Clostridioides Infection in Patients with Inflammatory Bowel Disease
  Mi Rae Lee, Eun Soo Kim
  The Korean Journal of Gastroenterology.2022; 80(2): 66.     CrossRef
• Viral Hepatitis in Patients with Inflammatory Bowel Disease
  Seung Hwan Shin, Sang Hyoung Park
  The Korean Journal of Gastroenterology.2022; 80(2): 51.     CrossRef
• Exploration of Potential Gut Microbiota-Derived Biomarkers to Predict the Success of Fecal Microbiota Transplantation in Ulcerative Colitis: A Prospective Cohort in Korea
  Gi-Ung Kang, Sowon Park, Yeongyun Jung, Jai J. Jee, Min-Sueng Kim, Seungjun Lee, Dong-Woo Lee, Jae-Ho Shin, Hong Koh
  Gut and Liver.2022; 16(5): 775.     CrossRef
• Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?
  Suhyun Park, Sang Hyoung Park
  Gut and Liver.2022; 16(5): 663.     CrossRef
• Microbial Modulation in Inflammatory Bowel Diseases
  Jongwook Yu, Jae Hee Cheon
  Immune Network.2022;[Epub]     CrossRef
• Using next-generation sequencing to develop a Shigella species threshold and profile faecal samples from suspected diarrhoea cases
  Ann Smith
  Folia Microbiologica.2021; 66(3): 399.     CrossRef
• Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection
  Sarah Rotondo‐Trivette, Beibei Wang, Christopher Gayer, Riddhi Parsana, Yihui Luan, Fengzhu Sun, Sonia Michail
  Alimentary Pharmacology & Therapeutics.2021; 54(6): 792.     CrossRef
• Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network
  Gabrio Bassotti, Alessandro Fruganti, Giovanni Maconi, Pierfrancesco Marconi, Katia Fettucciari
  Journal of Inflammation Research.2021; Volume 14: 7443.     CrossRef

Citations

Citations to this article as recorded by  

• Effectiveness of Fecal Microbiota Transplantation in Nociplastic Pain Management: A Systematic Review
  Sebastián Eustaquio Martín Pérez, Hakim Al Lal Abdel Lah, Nelson Hernández García, Umabel Aaron Reyes Carreño, Isidro Miguel Martín Pérez
  Gastrointestinal Disorders.2025; 7(1): 5.     CrossRef
• Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
  Kevin J. McDonnell
  Journal of Clinical Medicine.2025; 14(6): 2040.     CrossRef
• Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA ® ) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trial
  Sahil Khanna, David Yoho, Daniel Van Handel, Brian J. Clark, Tahany Awad, Beth Guthmueller, Daniel Armandi, Whitfield Knapple, Nasia Safdar, Brian Baggott, Karen Simon, Paul Feuerstadt
  Therapeutic Advances in Gastroenterology.2025;[Epub]     CrossRef
• Retrospective subgroup analysis of fecal microbiota, live-jslm (REBYOTA ® ) administered by colonoscopy under enforcement discretion for the prevention of recurrent Clostridioides difficile infe
  Whitfield L. Knapple, David S. Yoho, Alexander Sheh, Joan Thul, Paul Feuerstadt
  Therapeutic Advances in Gastroenterology.2024;[Epub]     CrossRef
• Non-alcoholic fatty liver disease and gut microbial dysbiosis- underlying mechanisms and gut microbiota mediated treatment strategies
  Muthukumaran Jayachandran, Shen Qu
  Reviews in Endocrine and Metabolic Disorders.2023; 24(6): 1189.     CrossRef
• Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease
  Raseen Tariq, Molly B Disbrow, John K Dibaise, Robert Orenstein, Srishti Saha, Dipesh Solanky, Edward V Loftus, Darrell S Pardi, Sahil Khanna
  Inflammatory Bowel Diseases.2020; 26(9): 1415.     CrossRef
• Faecal Microbiota Transplantation is Effective for the Initial Treatment of Clostridium difficile Infection: A Retrospective Clinical Review
  Niloufar Roshan, Annabel K. Clancy, Thomas J. Borody
  Infectious Diseases and Therapy.2020; 9(4): 935.     CrossRef